Company Directory › Robotics › Complete Robots & Platforms › Stereotaxis vs Stryker (Mako)
Stereotaxis vs Stryker (Mako)
Stereotaxis and Stryker (Mako) are both complete robots & platforms companies. Their verified profiles differ on headquarters, industry focus, founding year and markets served. The table below sets out only those rows; everything else is on each company's own profile. Facts verified 6 November 2026.
Where they differ
| Company | Stereotaxis | Stryker (Mako) |
|---|---|---|
| Headquarters | St. Louis, Missouri, United States | Kalamazoo, Michigan, United States |
| Industry | Surgical robotics — robotic magnetic navigation systems for minimally invasive endovascular intervention | Surgical robotics — orthopaedic robotic-arm assisted surgery (Stryker Corporation) |
| Founded | 1990 | 2006 |
| Markets served | Hospitals and electrophysiology labs in the United States, Europe, Asia and other markets | Global; Mako systems installed in 47 countries (company-stated), including every US state |
How Stereotaxis and Stryker (Mako) differ
Stereotaxis is headquartered in St. Louis, Missouri, in the United States, and was founded in 1990, while Stryker is headquartered in Kalamazoo, Michigan. Their industries sit in different surgical fields: Stereotaxis works in surgical robotics through Robotic Magnetic Navigation, where computer-controlled magnetic fields steer magnetic catheters and guidewires through blood vessels and heart chambers for minimally invasive endovascular intervention, whereas Stryker's Mako SmartRobotics platform covers orthopaedic robotic-arm assisted surgery. On founding, Stryker's record gives 2006 as the first Mako robotic-arm assisted procedure, with the platform originating at MAKO Surgical Corp., acquired by Stryker in 2013, while parent Stryker itself was founded in 1941. Stereotaxis serves hospitals and electrophysiology labs in the United States, Europe, Asia and other markets; Stryker describes a global market, with Mako systems installed in 47 countries, company-stated, including every US state, and orthopaedic robotics facilities in Portage, Michigan and Fort Lauderdale, Florida. Their public funding also differs in form: Stereotaxis is listed on NYSE American under STXS, while parent Stryker Corporation is listed on the New York Stock Exchange under SYK, and Mako is an internal product platform, not a separately funded entity. Electrophysiology teams should read Stereotaxis; orthopaedic surgery teams should read Stryker.
Frequently asked questions
What is the main difference between Stereotaxis and Stryker (Mako)?
Stereotaxis is based in St. Louis, Missouri, United States and Stryker (Mako) in Kalamazoo, Michigan, United States; they also differ on industry focus, founding year, markets served. The table above sets out both companies' entries row by row.
Are Stereotaxis and Stryker (Mako) in the same country?
Yes. Stereotaxis is based in St. Louis, Missouri, United States and Stryker (Mako) in Kalamazoo, Michigan, United States, both in United States.
Can one sourcing request reach both Stereotaxis and Stryker (Mako)?
Yes. Stereotaxis can be reached through stereotaxis.com and Stryker (Mako) through stryker.com, or post one sourcing request and let both answer if they fit.
Does GlobleMatch rank Stereotaxis above Stryker (Mako), or Stryker (Mako) above Stereotaxis?
Neither. There is no pay-to-rank and no paid placement in comparisons; order and content come from verified profile facts only.
Run Stereotaxis or Stryker (Mako)? Claim your free profile to keep your facts current.
Full profiles, with every fact and its source: Stereotaxis and Stryker (Mako). Profile facts last verified: Stereotaxis on 6 November 2026, Stryker (Mako) on 6 November 2026.